logo-loader
AIM:AIM

NeuroproteXeon Ltd

Receive alerts
Market:
AIM
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

A late-stage clinical-stage pharmaceutical and drug delivery device company developing and commercializing the proprietary use and delivery of XENEX (xenon) inhalation gas